Combination of contract research organizations (CROs) to the pharmaceutical and medical device industries will build on existing close collaboration
Hunt Valley, MD and Northbrook, IL – Two leading contract research organizations (CROs) to the pharmaceutical industry, H2O Clinical, based in Hunt Valley, Maryland and Northbrook, Illinois-based Pharma Start, today announced their plan to merge. The companies, which provide a range of outsourced research services to the pharmaceutical industry, already have a history of close collaboration. Each company will continue to operate as it has in the past, and there will be no disruption to current operations or customer contracts.
The combined companies will provide full-service CRO services in biostatistics, data management, clinical operations and medical writing, as well as other ancillary services to the pharmaceutical, medical device and biotechnology industries.
“H2O and Pharma Start already have a very collaborative relationship,” said Eugenia Henry, President of H2O Clinical. “It made perfect sense to build on this strong and successful relationship by combining forces to grow our businesses in complementary areas.” Earl Henry, Chief Medical Officer at H2O Clinical, added, “We’re very excited to offer a full service CRO to the marketplace and our existing clients.”
“The CRO and outsourced pharma contract services market are expected to continue to grow over the next several years,” said Chrissy Fleming, President of Pharma Start. “This growth is a reflection of the ongoing increase in R&D spending around the world and the growth in outsourcing, largely driven by clinical trials becoming more complicated and challenging. Together, Pharma Start and H2O are even more strongly positioned to capitalize on these trends by providing a complete set of premium CRO services to our valued customers.”
About H2O Clinical
H2O Clinical, LLC is a contract research organization focused on data management, statistical programming and biostatistics services in support of pharmaceutical and medical device clinical trials. The Company is based in Hunt Valley, MD. For more information, please visit: www.h2oclinical.com.
About Pharma Start
Pharma Start, based in Northbrook, IL, provides outsourced services, including preclinical assessment, clinical development, clinical pharmacology, translational medicine, medical writing, and regulatory submission and lifecycle management, supporting global pharmaceutical, biotechnology, and medical device companies. For more information, please visit www.pharma-start.com.
Truqap Combination Shines in Phase III Trial for Prostate Cancer
November 26th 2024Data from the CAPItello-281 trial show Truqap alongside abiraterone and androgen deprivation therapy achieved a statistically significant and clinically meaningful improvement in radiographic progression-free survival.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.